ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,622, issued on Oct. 21, was assigned to Hudson Institute of Medical Research (Clayton, Australia).
"Oligonucleotides" was invented by Michael Gantier (McKinnon, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to oligonucleotides that maintain a Toll-Like Receptor 7 (TLR7) response and/or which potentiate Toll-Like Receptor 8 (TLR8) sensing."
The patent was filed on June 22, 2023, under Application No. 18/213,116.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&...